North American Brain Tumor Consortium

Field Hierarchy

Parent
Phase i study 0 papers	Disease free survival 0 papers	Progression-free survival 21.6k papers	Temozolomide 16.5k papers
Maximum tolerated dose 1,746 papers
Current
North American Brain Tumor Consortium papers
Child

Trends

Notes

History